Most common oppounistic infection in HIV, globally ?
**Core Concept**
The question is testing the knowledge of the most common opportunistic infection in HIV patients worldwide. Opportunistic infections are conditions that take advantage of a weakened immune system, typically caused by HIV/AIDS. These infections can be caused by bacteria, viruses, fungi, or protozoa.
**Why the Correct Answer is Right**
The most common opportunistic infection in HIV patients globally is tuberculosis (TB). This is because TB is a widespread disease that affects millions of people worldwide, and individuals with HIV/AIDS are more susceptible to developing TB due to their compromised immune system. The bacteria that cause TB, Mycobacterium tuberculosis, can reactivate in HIV-positive individuals, leading to active TB disease. The CD4 cell count is a key factor in determining the risk of TB in HIV-positive individuals. A low CD4 cell count increases the risk of reactivation of TB.
**Why Each Wrong Option is Incorrect**
**Option A:** Pneumocystis jirovecii pneumonia (PCP) is another common opportunistic infection in HIV patients, but it is not the most common globally. PCP is more common in developed countries with access to antiretroviral therapy.
**Option B:** Toxoplasmosis is a common opportunistic infection in HIV patients, but it is not the most common globally. Toxoplasmosis is more common in regions with high prevalence of Toxoplasma gondii infection.
**Option C:** Cryptococcal meningitis is a serious opportunistic infection in HIV patients, but it is not the most common globally. Cryptococcal meningitis is more common in regions with high prevalence of Cryptococcus neoformans infection.
**Clinical Pearl / High-Yield Fact**
TB is a major public health concern in many parts of the world, and HIV/AIDS increases the risk of developing TB. Screening for TB in HIV-positive individuals is essential, especially in areas with high TB prevalence.
**Correct Answer:** B. Toxoplasmosis is the second most common opportunistic infection after TB in HIV patients globally.